ZYNRELEF Drug Patent Profile
✉ Email this page to a colleague
When do Zynrelef patents expire, and when can generic versions of Zynrelef launch?
Zynrelef is a drug marketed by Heron Theraps Inc and is included in one NDA. There are sixteen patents protecting this drug.
The generic ingredient in ZYNRELEF is bupivacaine; meloxicam. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the bupivacaine; meloxicam profile page.
DrugPatentWatch® Generic Entry Outlook for Zynrelef
Indicators of Generic Entry
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ZYNRELEF?
- What are the global sales for ZYNRELEF?
- What is Average Wholesale Price for ZYNRELEF?
Summary for ZYNRELEF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for ZYNRELEF |
| What excipients (inactive ingredients) are in ZYNRELEF? | ZYNRELEF excipients list |
| DailyMed Link: | ZYNRELEF at DailyMed |
US Patents and Regulatory Information for ZYNRELEF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heron Theraps Inc | ZYNRELEF KIT | bupivacaine; meloxicam | SOLUTION, EXTENDED RELEASE;PERIARTICULAR | 211988-003 | May 12, 2021 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Heron Theraps Inc | ZYNRELEF KIT | bupivacaine; meloxicam | SOLUTION, EXTENDED RELEASE;PERIARTICULAR | 211988-002 | May 12, 2021 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Heron Theraps Inc | ZYNRELEF KIT | bupivacaine; meloxicam | SOLUTION, EXTENDED RELEASE;PERIARTICULAR | 211988-003 | May 12, 2021 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
